— Bipartisan members sharply question CMS Administrator why Alzheimer’s drugs aren’t reasonable and necessary — WASHINGTON, April 26, 2023 /PRNewswire/ — Today, the Alzheimer’s Association brought its purple presence again to Capitol Hill, urging access to FDA-approved Alzheimer’s…